Investors Encouraged to Take Action Against Outset Medical, Inc.
In a significant legal development, investors facing substantial losses have the opportunity to step forward and lead a securities fraud class action lawsuit against Outset Medical, Inc. This initiative has been announced by Glancy Prongay & Murray LLP, emphasizing the company's commitment to representing the interests of affected investors.
Understanding the Class Period
The class action pertains to a specific time frame known as the Class Period, which spans from August 1, 2022, to August 7, 2024. This period is crucial as it serves as the basis for identifying individuals and entities that may have suffered financial losses due to alleged misleading statements by Outset Medical.
Deadline for Lead Plaintiff Submission
For those interested in taking the lead as plaintiffs in this lawsuit, it is important to note the deadline for submission. Investors must act before October 28, 2024, to ensure their voices are heard in this pivotal case.
Allegations Highlighting Company Misconduct
The complaint against Outset Medical outlines several serious allegations. Key among them is the failure to disclose crucial information regarding the marketing of their Tablo products. It is claimed that these products were promoted for continuous renal replacement therapy, which has not been approved by the FDA.
Implications of FDA Approval on Sales
As a result of these actions, Outset Medical may have been forced to submit an additional 510(k) application for the Tablo products, leading to potential sales cessation while waiting for FDA approval. Furthermore, the company lacked the necessary sales team and processes to effectively promote Tablo products, adversely affecting their anticipated revenue growth.
What Investors Can Do
Investors seeking to assert their rights in this class action shouldn't hesitate to reach out. Interested parties can submit their information through a simple online form available at Glancy Prongay & Murray LLP's website. Additionally, Charles H. Linehan is available for direct inquiries by phone or email, providing a pathway for investors to better understand their options.
Join the Class Action Class
It’s important to remember that joining this class action does not necessitate immediate action. Investors can retain legal counsel or simply remain passive members of the class. However, staying informed and engaged with any developments is strongly recommended.
Continuous Updates on Legal Proceedings
Investment communities should keep an eye on any updates related to this case. Follow Glancy Prongay & Murray LLP on their various social media platforms for latest news on the lawsuit against Outset Medical. Staying updated will help investors make informed decisions regarding their participation in the class action.
Your Rights Matter
Whether you have already experienced losses or are seeking to gain insight into your rights as an investor, there are resources available. Don't hesitate to take advantage of these opportunities to learn more about your options related to Outset Medical, Inc.
Frequently Asked Questions
What is the purpose of the class action against Outset Medical?
The class action aims to address allegations of securities fraud related to misleading information about Outset Medical's products.
Who can participate in the class action lawsuit?
Any investor who suffered losses during the defined Class Period can potentially participate in the class action.
What are the key dates to remember for this case?
Important dates include the Class Period from August 1, 2022, to August 7, 2024, and the lead plaintiff submission deadline on October 28, 2024.
How can I learn more about my rights as an investor?
Investors can reach out to Charles H. Linehan at Glancy Prongay & Murray LLP or visit their website for more information.
Is there any cost to participate in the lawsuit?
Joining the class action typically involves no upfront costs, although investors may choose to hire their own legal representation.
